Recently, in accordance with the relevant provisions of the Implementation Measures of Pingshan District on the Cultivation, Introduction, and Management of Biopharmaceutical Industry Talent issued by the Human Resources Bureau of Pingshan District, Shenzhen, our company was successfully approved as a University Student Internship Base in Pingshan District, Shenzhen.

The construction of university student internship bases is a proactive measure by the Pingshan District Government to promote the strategy of prioritizing talent development, stimulate the innovative and entrepreneurial vitality of talent, and achieve a win-win outcome for both enterprise talent recruitment and university graduate employment. It opens up university-enterprise cooperation channels and promotes the development of the biopharmaceutical industry. Shenzhen Cell Valley's approval for the internship base designation is recognition by the Pingshan District Government of our company's development, research strength, and talent cultivation efforts.

Shenzhen Cell Valley is a one-stop comprehensive outsourcing service provider focused on the cell and gene therapy industry, and is currently the only CRO/CDMO company with GMP industrial-scale production capability for clinical-grade retroviral vectors. Shenzhen Cell Valley provides full-cycle services to enterprises and research institutions in the cell and gene therapy field—from vector construction to cell production, from non-clinical research to clinical research, including IIT and IND application support services, as well as cultivating high-quality professional talent needed by the cell and gene therapy industry for the nation.

Since its establishment, with the strong support of the government and professionals from all sectors, Shenzhen Cell Valley has received the following honors:

01  2022 Shenzhen Major Project
Shenzhen Cell Valley's "One-Stop Cell and Gene Therapy CRO/CDMO Service Platform – South China Cell Factory Project" was approved as a 2022 Shenzhen Major Project.

02  Shenzhen Biopharmaceutical Industry Major Public Service Platform
The company is exploring solutions to the "bottleneck" technical challenges of core raw materials in cell and gene therapy and the technical challenges of high-quality retroviral vector industrial-scale production, and has received tens of millions of yuan in government funding support.

03  2022 Pingshan District Top 10 Innovation Platforms
Building a new business ecosystem service platform to provide biopharmaceutical enterprises with full-cycle services including viral vector production, cell product manufacturing, application support, and professional talent cultivation.

Shenzhen Cell Valley will actively fulfill its social responsibilities, focus on cultivating innovative and entrepreneurial talent, provide university students with broader development space and platforms, promote deep integration of industry-academia-research-application, and lead a new ecosystem in the biopharmaceutical industry. Taking the university student internship base as an opportunity, our company hopes to establish deep cooperation with more universities, provide more practical education and training services for university students, jointly cultivate professional and technical talent, and contribute to the nation's development.